The U.S. dollar edged higher against some of its peers including the yen and euro on Thursday as markets weighed fresh tariff ...

Stock slid after the company posted disappointing results driven by falling sales in its crucial market China, which accounts ...

The Swiss giant is planning to increase the capacity of production plants in Veracruz, Guanajuato, Querétaro and the State of ...

Skittish Chinese consumers at home or abroad dragged down the Swatch Group: The Swiss company’s 2024 net income dropped 75 percent to 219 million Swiss francs, or $242 million at current exchange ...

Swiss Biotechnology firm Lonza, which purchased the Genentech facility in Vacaville last year, reported an income of 6.6 billion in Swiss francs (CHF) for the year 2024, which converts to about ...

The contraction in Swiss watch exports intensified in December with a decline of 5.4%, resulting in a total value of 2.0 billion Swiss francs ($2.21 billion), according to data from the Federation of ...

The Swiss government is ending its development aid programmes for Zambia, Albania and Bangladesh. This decision comes after the parliament allocated less funding for foreign aid in December than the ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end report that it's in a stronger position going into 2025 thanks to improved ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

On 1 July 2025, the 100th anniversary of the CHF 100 gold Vreneli will be marked by the issuance of a commemorative coin. This special coin 100 Years 100-Franc Vreneli echoes the design and history of ...

After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year on the market. | After repeatedly wowing investors, Roche’s star eye med ...